|[January 20, 2014]
Research and Markets: Global Protein Therapeutics Market Outlook 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/3tq942/global_protein)
has announced the addition of the "Global
Protein Therapeutics Market Outlook 2018" report to their
Protein based therapies have found a prominent place in the
biopharmaceutical industry since the launch of the human insulin
product. They have become one of the most effective clinical methods to
treat a wide spectrum of diseases ranging from cancer to metabolic
disorders. The market holds tremendous potential for future growth and
it is estimated that by the end of 2018, it may reach the mark of US$
165 Billion as new products (especially monoclonal antibodies in the
advanced clinical phase) may enter the sector.
According to this new research report, Global Protein Therapeutics
Market Outlook 2018, a large number of market players has been
developing monoclonal antibodies (mAbs). This research has found that
mAbs contribute the largest shares in the number of protein therapeutic
products under pipeline. The report, in this context, gives a
comprehensive analysis of the current and future patterns of revenue
generation with respect to mAbs and other segments.
Through in-depth and prudent analysis of the developments taking place
at the global level, the authors have observed that te US holds a
dominant position in the global protein therapeutics market as the
country provides a major proportion of the products' sales. However, the
researchers for this report have come up with an analysis that the
future landscape of the market may find positive developments from Asian
countries as huge patients' population and increasing disposable incomes
may turn out to be a win-win condition for industry participants.
The report also covers an advanced phase drug analysis. This chapter
lists all the protein therapeutics of the major players which are in the
third phase of the clinical trial. This analysis will help the client in
understanding the potential market for the future. It also helps
understand the major segments, indications and players in Protein
Therapeutics that will continue to rule the market.
The report takes into account all the key aspects of the worldwide
protein therapeutics market and projects the market during the period
2012-2018. It prudently analyzes all the industry segments in an
effective manner by focusing on major players and products, recent
developments, application support in terms of indications, geographical
performances and last but not the least, current and future market
sizes. Moreover, the report provides a summary of the recent trends that
may have an impact on the future industry performance.
At the end, the key players of the market have been enlisted. A brief
business overview of every player has been provided along with its
product portfolio. This is followed by the recent developments of the
player that may impact the market in the future. Overall, the report
will prove to be a complete source of knowledge and analysis for clients
and potential investors.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Global Protein Therapeutics Market
4. Industry Performance
5. Advanced Phase Drugs Analysis
6. Emerging Market Trends
7. Key Players
List of Tables
List of Charts
- Abbott Laboratories
- Amgen Inc.
- Biogen Idec Inc.
- Eli Lilly & Company
- Johnson & Johnson
- Merck Serono S.A.
- Novo Nordisk
- Roche Group
For more information visit http://www.researchandmarkets.com/research/3tq942/global_protein
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Cloud Computing 's Homepage ]